Orient Pharma Valuation
| 4166 Stock | TWD 37.00 0.05 0.14% |
At this time, the company appears to be overvalued. Orient Pharma holds a recent Real Value of NT$30.45 per share. The prevailing price of the company is NT$37.0. Our model determines the value of Orient Pharma from analyzing the company fundamentals such as Return On Equity of -14.97, operating margin of (79.63) %, and Price To Sales of 10.53 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Orient Pharma's price fluctuation is not too volatile at this time. Calculation of the real value of Orient Pharma is based on 3 months time horizon. Increasing Orient Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Orient stock is determined by what a typical buyer is willing to pay for full or partial control of Orient Pharma Co. Since Orient Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Orient Stock. However, Orient Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 37.0 | Real 30.45 | Hype 37.0 |
The intrinsic value of Orient Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Orient Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Orient Pharma Co helps investors to forecast how Orient stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Orient Pharma more accurately as focusing exclusively on Orient Pharma's fundamentals will not take into account other important factors: Orient Pharma Total Value Analysis
Orient Pharma Co is presently anticipated to have takeover price of 3.23 B with market capitalization of 3 B, debt of 287.34 M, and cash on hands of 64.58 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Orient Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.23 B | 3 B | 287.34 M | 64.58 M |
Orient Pharma Investor Information
The book value of the company was presently reported as 7.03. The company recorded a loss per share of 1.13. Orient Pharma had not issued any dividends in recent years. Based on the key measurements obtained from Orient Pharma's financial statements, Orient Pharma Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Orient Pharma Asset Utilization
One of the ways to look at asset utilization of Orient is to check how much profit was generated for every dollar of assets it reports. Orient Pharma holds a negative application of assets of -8.89 pct., losing NT$0.0889 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Orient Pharma Co shows how discouraging it operates for each dollar spent on its assets.Orient Pharma Profitability Analysis
The company reported the revenue of 285.29 M. Net Loss for the year was (176.29 M) with profit before overhead, payroll, taxes, and interest of 5.66 M.About Orient Pharma Valuation
Our relative valuation model uses a comparative analysis of Orient Pharma. We calculate exposure to Orient Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Orient Pharma's related companies.Orient Pharma Co., Ltd. researches, develops, manufactures, and sells drugs in Taiwan and internationally. Orient Pharma Co., Ltd. is a subsidiary of Orient Europharma Co., Ltd. ORIENT PHARMA operates under Drug Manufacturers - Major classification in Taiwan and is traded on Taiwan OTC Exchange.
8 Steps to conduct Orient Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Orient Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Orient Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Orient Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Orient Pharma's revenue streams: Identify Orient Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Orient Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Orient Pharma's growth potential: Evaluate Orient Pharma's management, business model, and growth potential.
- Determine Orient Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Orient Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Orient Stock Analysis
When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.